Qualifications:

MBBS

MD (Internal Medicine)

DM (Nephrology)

Professional Synopsis:

certified Nephrologist dedicated to providing comprehensive care for patients with kidney-related conditions. With a clinical focus that spans from early-stage Chronic Kidney Disease (CKD) to the management of end-stage kidney failure, believes that the best kidney care is proactive, personalized, and rooted in the latest medical evidence.

In an era where kidney disease is often a "silent" condition, specialized in identifying risks early. By managing the delicate balance of electrolytes, blood pressure, and bone health, they work to slow the progression of disease and improve the overall quality of life for every patient.

Areas Of Interest/ Expertise:

Comprehensive Kidney Care: Expert management of CKD and Glomerular diseases with a focus on slowing progression and treating protein-leaking disorders.

Advanced Hypertension Management: Specialized care for resistant and secondary hypertension utilizing the latest protocols for vascular protection.

Critical Care Nephrology: Providing life-saving support in intensive care settings, including CRRT for hemodynamically unstable patients.

Dialysis Oversight: Longitudinal care for patients requiring Hemodialysis and Peritoneal Dialysis to ensure optimal clearance and quality of life.

Renal Transplantation: Managing the full spectrum of care from pre-transplant work-up to post-transplant immunosuppression and follow-up.

Diagnostic & Interventional Procedures: Skilled in performing ultrasound-guided renal biopsies and placing temporary IJV and permanent tunneled dialysis catheters.

Accomplishments & Awards:

NATPUCON-2023 AND PRESENTED ORAL PAPER ON Low-Dose Irinotecan as a Non-Immunosuppressant Add-On Therapy for Membranous Nephropathy AND WON 2ND PRIZE

Membership:

• Indian Society of Nephrology
• Women in Nephrology India

Paper/Poster Presentations:

1. WCN-2025 PRESENTED POSTER TITLED -THE IMPACT OF RHABDOMYOLYSIS-INDUCED AKI ON PATIENT OUTCOMES
2. NATPUCON-2023 AND PRESENTED ORAL PAPER ON Low-Dose Irinotecan as a Non-Immunosuppressant Add-On Therapy for Membranous Nephropathy.
3. AVATAR 2024 -PRESENTED ORAL PAPER ON CENTRAL VEIN STENOSIS-CASE SERIES

Publications:

1. Central vein stenosis- prevalence, clinical characteristics, outcome and its impact on dialysis access- Journal of Artificial Organs. 2025 Feb 21, Springer's publication  Singh Sai Sindhu,dharnaidhar reddy, Kumar Manoj, Elayaperumal Indhumathi
2. Hepatorenal Syndrome - Acute Kidney Injury in Decompensated Liver Disease: Clinical Characteristics, Risk Factors, Ultrasound Applications, and Outcomes. Conducted an in-depth study on ultrasound applications in predicting AKI in DLD, focusing on clinical and imaging predictors.(published in Italian journal of nephrology-2025) Dharnaidhar Reddy, Sai Sindhu Singh, Elayaperumal Indhumathi
3. Balancing Efficacy, Quality of Life, and Cost-Effectiveness: A Comparative Study of Desidustat and Erythropoietin in Chronic Kidney Disease Patients on Hemodialysis (published in Italian journal of nephrology-2025) Dharnaidhar Reddy, Sai Sindhu Singh, Kumar Manoj, Elayaperumal Indhumathi
4. Usefulness of low dose toposiomerase I inhibitor (irinotecan )as add-on therapy along with low dose rituximab in lupus nephritis flare patients with deteriorating renal function-our initial experience, Journal of Clinical Nephrology and Research, January 2023, Ravichandran P, Sai Sindhu Singh, Soundararajan .P 
5. Beyond the usual suspects:a case of monoclonal gammopathy with unexpected thrombotic complications (accepted, yet to publish )